£1
No changevs Jul 2024Active14994295Private limited companyGreenford
AFRIVAX LTD
Significant control: Eluemuno Richard Blyden (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Afrivax Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Afrivax Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
AFRIVAX LTD is an active private limited company (company number 14994295) incorporated on 11 July 2023, registered in Greenford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 July 2025, showing net assets of £1 and cash of £1. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the lower half of 151 comparable companies in Greater London (median £200, upper quartile £53k).
02
Ownership and control
- Dr. Eluemuno Richard Blyden
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 11 July 20233 yrs ago
- Next accounts due
- 30 April 2027in 188 days
- Confirmation statement due
- 25 July 2027in 274 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
£1
No changevs Jul 2024Not reported
Not reported
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2025 | £1 | £1 | — | — | — | — | — |
| 31 July 2024 | £1 | £1 | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1 at 31 July 2025
- Incorporated two to five years agoIncorporated 11 July 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 274 days
- Next accounts duein 188 days
- Accounts period endNet assets £1 · dormant accounts
- Accounts period endNet assets £1 · dormant accounts
- Incorporated
08
Similar companies in Greater London
- DVO BIOTECH LIMITEDDartford · inc. Jul 2023
- PYVSEARCH LTDHounslow · inc. Jul 2023
- BIOCODE CONSULTANCY LIMITEDCroydon · inc. Jul 2023
- MAX BIOTECH SUBCO LIMITEDPinner · inc. Jun 2023
- HEOR & ACCESS CONSULTING LTDChertsey · inc. May 2023
- REJUVENEXPERT LIMITEDBeckenham · inc. May 2023
All companies incorporated on 11 July 2023 · in Jul 2023.
09
Reminders for AFRIVAX LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.